Table 2.
Patients’ characteristics at time of admission.
| Parameter | (1) Whole Cohort |
(2) Survivor |
(3) Non-Survivor |
p-Value (2) vs. (3) |
|---|---|---|---|---|
| Number of Patients | 274 (100%) | 71 (25.9%) | 203 (74.1%) | |
| Mean Age [years] | 60.0 ± 14.3 | 59.8 ± 14.6 | 60.0 ± 14.2 | 0.9085 |
| Female Gender | 73 (26.6%) | 22 (32.0%) | 50 (24.6%) | 0.2720 |
| Low-Flow Time [min] | 53.8 ± 28.9 | 46.0 ± 27.9 | 56.6 ± 28.8 | 0.0086 |
| Shockable Initial Rhythm | 129 (47.1%) | 42 (59.2%) | 87 (42.8%) | 0.0162 |
| SAPS 2 | 70.7 ± 7.4 | 70.0 ± 8.0 | 71.0 ± 7.2 | 0.3187 |
| SOFA | 11.7 ± 2.3 | 11.6 ± 2.4 | 11.8 ± 2.2 | 0.5266 |
| SAVE | −0.47 ± 4.5 | 0.35 ± 4.8 | −0.76 ± 4.4 | 0.0743 |
| PREDICT Score 6h [%] | 32 ± 22 | 42 ± 17 | 29 ± 23 | <0.0001 |
| Out-of-Hospital Cardiac Arrest | 127 (46.4%) | 35 (49.3%) | 92 (45.3%) | 0.5631 |
| Initial Lactate Level [mmol/L] | 10.6 ± 7.8 | 7.9 ± 4.5 | 11.6 ± 8.4 | 0.0005 |
| Comorbidities: | ||||
| Arterial Hypertension | 104 (38.0%) | 30 (42.5%) | 74 (36.4%) | 0.3860 |
| Chronic Kidney Disease | 48 (17.5%) | 12 (16.9%) | 36 (17.7%) | 0.8738 |
| Chronic Liver Disease | 16 (5.8%) | 6 (8.5%) | 10 (4.9%) | 0.2756 |
| Chronic Lung Disease | 38 (13.9%) | 10 (14.1%) | 28 (13.8%) | 0.9512 |
| Coronary Artery Disease | 152 (55.5%) | 41 (57.8%) | 111 (54.7%) | 0.6545 |
| Diabetes Mellitus | 61 (22.3%) | 16 (22.5%) | 45 (22.2%) | 0.9489 |
| Hypercholesterinemia | 52 (19.0%) | 15 (21.1%) | 37 (20.3%) | 0.5917 |
| Nicotine | 68 (24.8%) | 25 (35.2%) | 43 (23.6%) | 0.0185 |
| Peripheral Artery Disease | 17 (6.2%) | 7 (9.9%) | 10 (4.9%) | 0.1380 |
|
Positive Cardiovascular
Family History |
25 (9.1%) | 6 (8.5%) | 19 (10.4%) | 0.8189 |
Data given in mean ± standard deviation or number of patients (percentage). p-values are calculated between survivors and non-survivors. (significance level p-value < 0.05).